Gikas S. Mageras

Gikas S. Mageras

Auto-generated profile, based on publicly available information

Gikas S. Mageras

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2006 in Medical Physics
Verified
Journal Article
Open access
PKPaul J. Keall
Paul J. Keall
GMGig S. Mageras
Gig S. Mageras
JBJames M. Balter
James M. Balter
RERichard S. Emery
Richard S. Emery
KFKenneth M. Forster
Kenneth M. Forster
EYEllen Yorke
Ellen Yorke
This document is the report of a task group of the AAPM and has been prepared primarily to advise medical physicists involved in the external‐beam radiation therapy of patients with thoracic, abdominal, and pelvic tumors affected by respiratory motion. This report describes the magnitude of respiratory motion, discusses radiotherapy specific problems caused by respiratory motion, explains techniques that explicitly manage respiratory motion during radiotherapy and gives recommendations in the application of these techniques for patient care, including quality assurance (QA) guidelines for these devices and their use with conformal and intensity modulated radiotherapy. The technologies covered by this report are motion‐encompassing methods, respiratory gated techniques, breath‐hold techniques, forced shallow‐breathing methods, and respiration‐synchronized techniques. The main outcome of this report is a clinical process guide for managing respiratory motion. Included in this guide is the recommendation that tumor motion should be measured (when possible) for each patient for whom respiratory motion is a concern. If target motion is greater than , a method of respiratory motion management is available, and if the patient can tolerate the procedure, respiratory motion management technology is appropriate. Respiratory motion management is also appropriate when the procedure will increase normal tissue sparing. Respiratory motion management involves further resources, education and the development of and adherence to QA procedures.

1 October 1999 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
JHJoseph Hanley
Joseph Hanley
MDMarc M. Debois
Marc M. Debois
DMDennis Mah
Dennis Mah
GMGikas S. Mageras
Gikas S. Mageras
ARAdam Raben
Adam Raben
GKGerald J. Kutcher
Gerald J. Kutcher

20 December 2002 in Medical Physics
Verified
Journal Article
Closed access
PDF file
EFE. C. Ford
E. C. Ford
GMG. S. Mageras
G. S. Mageras
EYE. Yorke
E. Yorke
CLC. C. Ling
C. C. Ling

1 August 2000 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
KRKenneth E Rosenzweig
Kenneth E Rosenzweig
JHJoseph Hanley
Joseph Hanley
DMDennis Mah
Dennis Mah
GMGig Mageras
Gig Mageras
MHMargie Hunt
Margie Hunt
SLSteven A Leibel
Steven A Leibel

8 November 2004 in Medical Physics
Verified
Journal Article
Closed access
PDF file
SNS. A. Nehmeh
S. A. Nehmeh
YEY. E. Erdi
Y. E. Erdi
TPT. Pan
T. Pan
APA. Pevsner
A. Pevsner
KRK. E. Rosenzweig
K. E. Rosenzweig
JHJ. L. Humm
J. L. Humm

1 January 2004 in Seminars in Radiation Oncology
Verified
Journal Article
Open access
GMG Mageras
G Mageras
EYE Yorke
E Yorke
We examine 2 strategies for reducing respiration-induced organ motion in radiation treatment: deep inspiration breath hold (DIBH) and respiratory gating. DIBH is a controlled breathing technique in which the patient performs a supervised breath hold during treatment. The technique offers 2 benefits: reduced respiratory motion from the breath hold and increased normal tissue sparing from the increased lung volume. In respiratory-gated treatment, a device external to the patient monitors breathing and allows delivery of radiation only during certain time intervals, synchronous with the patient's respiratory cycle. Gated treatment offers reduced respiratory motion with less patient effort than DIBH. We briefly survey the development of these 2 strategies, describe their clinical implementation for treatment of thoracic and liver tumors at the Memorial Sloan-Kettering Cancer Center, and discuss their advantages and limitations.